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PROCEEDINGS

Open Access

Evaluation of the power and type I error of
recently proposed family-based tests of
association for rare variants
Allison Hainline1†, Carolina Alvarez2†, Alexander Luedtke3, Brian Greco4, Andrew Beck5, Nathan L Tintle6*
From Genetic Analysis Workshop 18
Stevenson, WA, USA. 13-17 October 2012

Abstract
Until very recently, few methods existed to analyze rare-variant association with binary phenotypes in complex
pedigrees. We consider a set of recently proposed methods applied to the simulated and real hypertension
phenotype as part of the Genetic Analysis Workshop 18. Minimal power of the methods is observed for genes
containing variants with weak effects on the phenotype. Application of the methods to the real hypertension
phenotype yielded no genes meeting a strict Bonferroni cutoff of significance. Some prior literature connects 3 of
the 5 most associated genes (p <1 × 10−4) to hypertension or related phenotypes. Further methodological
development is needed to extend these methods to handle covariates, and to explore more powerful test
alternatives.
Background
The advent of next-generation sequencing technology
has allowed researchers to actively consider the impact of
rare genetic variation on common disease. However,
novel statistical methodologies have been needed to
leverage the limited evidence provided by any singlenucleotide rare genetic variant (SNV). Two major classes
of tests, collapsing and variance components, have been
proposed for testing case-control association (see Ref. [1]
for an overarching framework that classifies and
describes the general behavior of the tests). Virtually all
of the recently proposed methods use the gene as the
unit of analysis with the goal of aggregating independent
genotype-phenotype association signals across the set of
SNVs in the gene to boost statistical power versus the
limited potential power from individually testing millions
of SNVs, many of which may be extremely rare (eg, singletons). This SNV-set testing approach is not only statistically reasonable, it is also biologically plausible, because
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it may be that separate, independent variations within the
protein encoding region of a gene could alter protein
structure and, ultimately, explain phenotypic diversity.
Practically, however, many of these methods have
shown limited utility to date. Arguably, this limitation is
the result of a host of factors, the most significant of
which is the lack of power that results from testing extremely rare genetic variations in case-control samples.
With this in mind, family-based study designs are
increasingly being considered in an effort to potentially
gain a better understanding of the role that rare genetic
variation plays in explaining the heritability of common
disease.
Despite this renewed interest in family-based designs,
few multimarker, rare-variant association tests for familybased data are available. We now briefly describe some
recently proposed methods in an effort to identify methods appropriate for analyzing a categorical phenotype
(hypertension) for relationships with rare variants in arbitrarily complex pedigrees (eg, multigenerational, not
nuclear, family) as required for our analysis of the Genetic
Analysis Workshop 18 (GAW18) data. Two recent papers
[2,3] propose methods of analyzing rare variants for quantitative traits in nuclear families. However, the methods
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described are not applicable to binary traits or more complex pedigrees. Another recent paper proposed a method
that utilizes family data to estimate SNV weights when
testing case-control data, but the family data is used only
to estimate weights, and case-control data is required to
use the method [4]. Recently, Schifano et al [5] extended
the popular SNV-set testing methods based on the kernel
machine framework, used for both common and rarevariant tests of association. This paper does not reference
software, so we do not consider it in this analysis.
The only paper containing methods meeting our criteria
for inclusion (binary phenotypes, complex pedigrees, and
available software) is by Zhu and Xiong [6], who propose a
set of methods that are applicable for categorical traits in
complex pedigrees. Their methods generally can be
described as adjusting the standard error of the null distribution using the kinship matrix in order to account for
the additional correlation observed in the sample as a
result of the complex pedigree structure.
In this paper, we will apply the methods of Zhu and
Xiong to investigate potential relationships between
simulated and real phenotypes and genes, where genes
consist of sets of SNVs within the gene. In particular, we
are curious about the ability of the methods to maintain
type I error and yield reasonable power for simulated
phenotypes. Furthermore, through our analysis of the
real phenotype, we will explore potential insights into
disease etiology for hypertension using the GAW18 data.

Methods
Sample and genes

In the GAW18 data, real phenotype data was available
for 855 individuals in pedigrees. We classified each of
the 855 individuals as either ever-hypertensive or notever-hypertensive based on whether the individual was
classified as hypertensive at any of up to 4 measurements (waves) at which phenotypic data was collected.
At 849 individuals, the simulated phenotype sample was
slightly smaller. When analyzing the simulated phenotype, we again focused on the (similarly defined) hypertension phenotype. In the GAW18 data, there were 200
separate phenotype simulations. Our analysis considers
only simulated phenotype #1.
SNVs were mapped to genes using a custom implementation of ANNOVAR, where an SNV is assigned to a
gene if it is contained within the start-stop position of
the gene [7]. To improve computational time in this preliminary analysis, we restricted the analysis to 6625 genes
containing between 2 and 200 SNVs.
Statistical tests

We applied 3 different family-based tests of association
considered by Zhu and Xiong [6]. The following sections
briefly summarize the methods. All tests were conducted
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using software provided by Zhu and Xiong, which is written in R, with further data analysis conducted using our
own custom R scripts. Most of the methods considered
by Zhu and Xiong utilize a correction factor, Pcorr, which
summarizes the additional correlation in the samples
occurring because of the complex pedigree structure.
Pcorr is a function of 2 times the kinship matrix. We used
2 approaches to compute the kinship matrix: (a) the theoretical kinship matrix as computed using the kinship2 R
package based on stated genetic relatedness of the individuals from GAW18 documentation and (b) the estimated
kinship matrix computed by estimating genetic relationships across 732,185 SNVs randomly sampled across the
genome using KING [8]. We briefly describe each test
below.
The generalized T2 test

Zhu and Xiong [6] propose a generalized T2 test, which
is a multivariate test comparing the mean allele counts
across t variants (eg, SNVs within a gene) between the
cases and controls; it is a multivariate version of the 2sample t-test. Li and Leal [9] considered the T2 test for
case-control data. Zhu and Xiong prove that dividing
the T 2 test statistic by P corr properly accounts for the
pedigree structure yielding a t df chi-squared test statistic assuming additive polygenic inheritance.
Combined multivariate and collapsing test for families

Of course, the downside to the T2 test is that in the presence of rare variants there can be power loss from the
large number of rare variants (t) present, and the
asymptotic distribution of the statistic may not be valid
when many extremely rare variants (eg, singletons) are
present. Thus, Li and Leal [9] proposed the combined
multivariate and collapsing (CMC) test whereby SNVs
with minor allele frequencies (MAFs) below a particular
threshold are “collapsed” into a single super variant. The
generalized T2 test is then applied to the (partially) collapsed data (the super variant plus all individual variants
above the threshold). Zhu and Xiong show that, similar
to the T2 test, adjusting the CMC T2 statistic using Pcorr
properly accounts for the pedigree structure. In our
implementation of CMC, we used 2 MAF cutoffs: 5%
and 0.5%.
Χmin2

For comparison, Zhu and Xiong also consider taking the
minimum p value from all single-marker tests within
the gene. Zhu and Xiong compute a single-marker
p value using either a Pearson χ 2 test or Fisher’s exact
test (depending on sample size) and then adjusting the
p value using P corr. To generate a gene-based p value,
we follow Zhu and Xiong and use the minimum p value
across all variant sites within the gene. However,
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Results
Our analysis consisted of 2 main parts: using the simulated phenotype and using the real phenotype to investigate potential genotype-phenotype relationships in the
sample. The results section is structured accordingly.

identified as significantly associated with the phenotype.
For example, when using the estimated kinship matrix, 1
causal gene, EPHA4, had a p <0.05 for all 3 approaches,
which controlled the type I error rate (T2, CMC5%, and
CMC0.5%). Of the remaining genes identified as significant by at least 1 of these 3 methods, most (6 of 10) had
p values less than 0.10 for 1 of the other 2 methods, and
all 10 had p values less than 0.18 for at least 1 of the
other 2 methods.

Simulation results

Real data analysis

We started by applying each of the tests described above
to all 6625 genes, in particular, testing for association
between the genotypes of the SNVs in each gene with
the simulated hypertension phenotype. Table 1 shows
the results of this analysis stratified by whether the gene
does (171 genes) or does not (6454 genes) contain at
least 1 causal SNV. Table 1 provides the percent of significant SNVs for genes containing both causal and noncausal SNV rates using a nominal a = 0.05.
As expected, χmin2 does not properly control the type I
error rate, but tests using the estimated kinship provide
good control of the type I error rate, and tests using the
real kinship matrix (ie, the kinship matrix based on stated relationships) appear slightly conservative. Overall,
the p values from the tests using the real and estimated
kinship matrices are highly correlated (Pearson and
Spearman correlations are all 0.99), with the estimated
kinship matrices providing lower p values on average.
Thus, we will use the estimated kinship matrix for all
subsequent analyses. Because of the inability of χmin2 to
control the type I error rate, we do not consider that
test in further analyses. Across all 6625 genes the Pearson correlation between p values from T2 and CMC5%
was 0.55 (Spearman = 0.54); between T2 and CMC0.5%
0.8 (Spearman = 0.80); and 0.67 between CMC5% and
CMC0.5% (Spearman = 0.67).
Table 1 also illustrates that the power across the 171
genes that contain at least 1 causal SNV is essentially
equivalent to the type I error rate. The low power may
be attributed in part to the fact that the average variance
in blood pressure explained by the causal SNVs in these
genes was only 0.04% (SD = 0.1%, range: 0% to 0.9%).
However, there was modest overlap in the causal genes

When we applied the 3 remaining tests to the real hypertension phenotype on the entire sample of 855 individuals using the estimated kinship matrix, no minimum
p values were below a Bonferroni-corrected alpha value
of 0.05/6625 = 7.5 × 10−6 for the 6625 genes. The minimum p value for any gene with CMC5% was 1 × 10−4. For
T 2 there were 5 genes with p values less than 1 × 10−4
(MYBPHL, ZNF496, TRAT1, DHX8, ST6GALNAC2),
with 1 of these (MYBPHL) being the only gene for
CMC0.5%% with a p value less than 1 × 10−4.

because we do not correct for multiple testing, we
expect the type I error rate to be inflated using this
approach.

Discussion
Few methods currently allow for the analysis of binary
phenotypes with rare variants in complex pedigrees. We
have applied 4 of the published methods to both real and
simulated phenotypes. While the methods appeared to
control the type I error rate for smaller genes (less than
200 SNVs), they performed poorly (low power) when the
variance in blood pressure was small. Although this finding is based on the simulation model for GAW18 data,
power to detect causal genes may still be a significant
hurdle in real analyses.
We considered the use of both the theoretical and estimated kinship matrices. We found that use of the theoretical kinship matrix proved slightly overconservative,
while using the estimated kinship matrix provided
empirical type I error rates in line with the nominal
levels. Even though the precise reasons for the overconservative nature of the theoretical kinship are unknown,
we surmise that cryptic relatedness and population stratification between pedigrees, which are not reflected in the
theoretical kinship matrix, will be controlled through use
of the estimated kinship matrix. Because these issues may

Table 1 Percent of significant genes at a = 0.05
6454 Genes not containing a causal SNV

171 Genes containing at least 1 causal SNV

Method

Estimated kinship

Real kinship

Estimated kinship

Real kinship

χmin2

40.6% (2621/6454)

34.4% (2221/6454)

41.5% (71/171)

33.9% (58/171)

T2

5.2% (333/6454)

3.2% (209/6454)

1.8% (3/171)

1.2% (2/171)

CMC5%
CMC0.5%

4.1% (267/6454)
5.3% (341/6454)

3.3% (210/6454)
3.6% (235/6454)

2.9% (5/171)
2.9% (5/171)

2.3% (4/171)
2.3% (4/171)
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be present in any data set, we recommend estimating
kinship matrices in practical applications of family-based
tests of association for rare-variant data.
Even though minor differences in power existed across
the 3 tests considered here (T2, CMC5%, and CMC0.5%),
each test will be most powerful for particular genetic
architectures. In particular, for truly causal genes the
proportions of causal rare or common variants versus
noncausal rare and common variants will determine
which method is best. Because the “best” method here
will be a product of the simulation strategy taken, we do
not wish to extrapolate this simulated genetic architecture to suggest the use of one approach over the others.
A companion paper [10] demonstrates that the type I
error rate for all methods considered here occurs as the
number of SNVs in the gene increases beyond 200. This
inflation is partly caused by the small sample size (n =
855) relative to the large number of SNVs in these causal genes. We consider alternative approaches in Ref.
[10] for genes containing more than 200 SNVs.
In applying the 3 tests to the real phenotype, we found
modest evidence of a relationship between a handful of
genes and hypertension. These genes are featured in a
modest amount of prior literature, suggesting their
potential association with blood pressure, cardiovascular
development, and renal function. In particular, ZNF496
is associated with preeclampsia (ie, hypertension during
pregnancy) [11] and malignant pheochromocytoma
tumors, which can lead to malignant hypertension [12].
ST6GALNAC2 is associated with susceptibility to IgAN,
which is commonly associated with hypertension (eg,
see Ref. [13]). MYBPHL is associated with low-density
lipoprotein (LDL) cholesterol [14]. TRAT1 and DHX8
have little exposure in the literature related to hypertension or related outcomes. We note, however, that none
of these genes reached a conservative (Bonferroni-corrected) significance threshold, nor did we replicate
SNVs known to be associated with hypertension in large
genome-wide association studies.
In addition to the lack of power from small sample
size and, potentially, the choice of analysis methods, we
note that our approach did not consider covariates
because the methods considered in this paper do not
provide obvious approaches to control covariates. As
noted in the introduction, there is a dearth of methods
available for the analysis of data like that in GAW18,
and we know of few methods currently available that
work for analysis of rare variants with binary traits on
complex pedigrees, allowing for control of covariates
and for which software is publicly available. With
increased interest in family-based designs for the analysis of rare-variant data, further methodological development is needed in this area.
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Conclusions
The application of methods for the analysis of rare-variant data collected on complex pedigrees for relationship
with a binary phenotype suggests the potential for modest power for large variant effects with a sample of 855
individuals, but minimal power for variants and genes
with weaker effects. Application of the methods to a
real phenotype found modest evidence of association
between the hypertension phenotype and five genes,
three of which have limited prior association with
hypertension-related phenotypes. Further methodological work is needed to develop more powerful methods
allowing for control of covariates in the analysis of complex pedigrees and for use on larger genes.
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